“…13 Notably, these pharmaceuticals all contain a fluorinated six-membered azaheterocycle, such as fluoro-pyridine or -pyrimidine structural sub-unit, and effective synthetic procedures at both discovery and manufacturing scales are well reported in the literature. [14][15][16][17][18][19][20][21] In contrast, it is particularly striking that pharmaceuticals bearing related five-membered azaheterocycles, such as fluorinated pyrroles, furans and thiophenes, are very rarely found in life science products and this is, in part, due to the lack of available, efficient and regioselective methodology for the synthesis of, for example, appropriate fluoropyrrole derivatives both for medicinal chemistry programmes and large scale synthesis.…”